Illumina Inc. (ILMN)
The price, the headline numbers and the latest news, in one place.
Illumina Inc. (ILMN) Stock Price, Analysis & Data
| Bid | 206.71 |
| Market Cap | 33.13B |
| Revenue (ttm) | 4.49B |
| Net Income (ttm) | 824M |
| 1.46 | |
| 5.51 | |
| 39.82 | |
| 35.99 | |
| P/B (ttm) | 11.67 |
| P/S (ttm) | 7.37 |
| Earnings Date | Oct 29, 2026 |
| Ask | 228.34 |
| Volume | 1,912,997 |
| Avg. Volume (20D) | 1,989,254 |
| Open | 212.94 |
| Previous Close | 213.24 |
| Day's Range | 208.62 - 220.43 |
| 52-Week Range | 88.00 - 220.43 |
| Analyst | Buy |
| Price Target | 211 (-3.83%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ILMN
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which s...
Financial Performance
In 2025, Illumina's revenue was 4.34B, a decrease of -0.66% compared to the previous year's 4.37B. Earnings were 850M, a decrease of -169.5%.
Financial StatementsAnalyst Forecast
According to 19 analyst ratings, the average rating for ILMN stock is "Buy". The 12-month stock price forecast is 211, which is downside of 3.83% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
